RIPK3 and diabetes mellitus: Although further investigation is needed to clarify the specific roles of RIPK3 in islet inflammation and β-cell death, these data indicate that therapies targeting RIPK3 could protect β-cells from diabetes-relevant cytotoxic stimuli.